Showing results (1721-1730 of 1,906) with videos related to

Sort By:
Pageof 191
Oncoimmunology|August 29, 2024
Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinomaVincenzo De Falco, Stefania Napolitano, Renato Franco, et al.
European Journal of Gastroenterology & Hepatology|April 28, 2023
Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinomaRaffaella Tortora, Nunzia Farella, Filomena Morisco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2025
CtDNA detection with low-pass whole genome bisulfite sequencing in RAS wild-type metastatic colorectal cancer: an exploratory objective of the VALENTINO trialPaolo Manca, Marta Paoli, Francesca Galardi, et al.
Journal of Viral Hepatitis|March 27, 2007
The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virusG Kafatos, C Anastassopoulou, A Nardone, et al.
Functional Neurology|April 11, 2018
Multicentre registry of brain-injured patients with disorder of consciousness: rationale and preliminary dataA Pascarella, S Fiorenza, O Masotta, et al.
Cells|August 29, 2020
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced PneumonitisPierpaolo Correale, Rita Emilena Saladino, Diana Giannarelli, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 5, 2024
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023Mario Fontán-Vela, Esther Kissling, Nathalie Nicolay, et al.
The Lancet. Gastroenterology & Hepatology|September 11, 2021
Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysisLia C M J Goltstein, Karina V Grooteman, Alba Rocco, et al.
Epidemiology and Infection|August 13, 2008
The European Sero-Epidemiology Network 2 (ESEN2): standardization of assay results for hepatitis A virus (HAV) to enable comparisons of seroprevalence data across 15 countriesC G Anastassopoulou, G Kafatos, A Nardone, et al.
Neoplasia (New York, N.Y.)|July 14, 2014
Pathway-centric integrative analysis identifies RRM2 as a prognostic marker in breast cancer associated with poor survival and tamoxifen resistanceNagireddy Putluri, Suman Maity, Ramakrishna Kommagani, et al.
Pageof 191